Skip to main content

Advertisement

SpringerLink
Log in

Alzheimer’s disease: A review of its visual system neuropathology. Optical coherence tomography—a potential role as a study tool in vivo

  • Review Article
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also play a role in the pathophysiology of the disease. Visual symptoms are frequent and are an early clinical manifestation; a number of psychophysiologic changes occur in visual function, including visual field defects, abnormal contrast sensitivity, abnormalities in color vision, depth perception deficits, and motion detection abnormalities. These visual changes were initially believed to be solely due to neurodegeneration in the posterior visual pathway. However, evidence from pathology studies in both animal models of AD and humans has demonstrated that neurodegeneration also takes place in the anterior visual pathway, with involvement of the retinal ganglion cells’ (RGCs) dendrites, somata, and axons in the optic nerve. These studies additionally showed that patients with AD have changes in retinal and choroidal microvasculature. Pathology findings have been corroborated in in-vivo assessment of the retina and optic nerve head (ONH), as well as the retinal and choroidal vasculature. Optical coherence tomography (OCT) in particular has shown great utility in the assessment of these changes, and it may become a useful tool for early detection and monitoring disease progression in AD. The authors make a review of the current understanding of retinal and choroidal pathological changes in patients with AD, with particular focus on in-vivo evidence of retinal and choroidal neurodegenerative and microvascular changes using OCT technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Burns A et al (2009) Alzheimer’s disease. BMJ 338:b158

    Article  PubMed  Google Scholar 

  2. Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344

    Article  CAS  PubMed  Google Scholar 

  3. Tsai Y, Lu B, Ljubimov AV et al (2014) Ocular changes in TgF344-AD rat model of Alzheimer’s disease. Invest Ophthalmol Vis Sci 55:523–534. doi:10.1167/iovs.13-12888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bird TD, Miller BL (2008) Alzheimer’s disease and primary dementias. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill, New York, NY, pp 2393–2406

    Google Scholar 

  5. Petersen RC (2011) Mild cognitive impairment. N Engl J Med 364:2227–2234. doi:10.1056/NEJMcp0910237

    Article  CAS  PubMed  Google Scholar 

  6. Rizzo M, Nawrot M (1998) Perception of movement and shape in Alzheimer’s disease. Brain 121(12):2259–2270

    Article  PubMed  Google Scholar 

  7. Murgatroyd C, Prettyman R (2001) An investigation of visual hallucinosis and visual sensory status in dementia. Int J Geriatr Psychiatry 16:709–713

    Article  CAS  PubMed  Google Scholar 

  8. Chapman FM, Dickinson J, McKeith I et al (1999) Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer’s disease: treatment implications. Am J Psychiatry 156:1983–1985

    CAS  PubMed  Google Scholar 

  9. Tzekov R, Mullan M (2013) Vision function abnormalities in Alzheimer disease. Surv Ophthalmol 59(4):414–433

    Article  PubMed  Google Scholar 

  10. Chang LYL, Lowe J, Ardiles A, Lim J, Grey AC (2014) Alzheimer’s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers. Alzheimers Dement 10:251–261

    Article  PubMed  Google Scholar 

  11. Drobny JV, Anstey KJ, Andrews S (2005) Visual memory testing in older adults with age-related visual decline: a measure of memory performance or visual functioning? J Clin Exp Neuropsychol 27:425–435

    Article  PubMed  Google Scholar 

  12. Hyman BT et al (2012) National Institute on aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1–13. doi:10.1016/j.jalz.2011.10.007

    Article  PubMed  PubMed Central  Google Scholar 

  13. Perl DP (2010) Neuropathology of Alzheimer’s disease. Mt Sinai J Med 77(1):32–42

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sawa GM, Wharton SB, Lince PG, Forster G, Matthews FE, Brayne C (2009) Medical research council cognitive function and ageing study. Age, neuropathology, and dementia. N Engl J Med 360(2302):9

    Google Scholar 

  15. Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol 49:53–66

    Article  CAS  PubMed  Google Scholar 

  16. Katz B, Rimmer S (1989) Ophthalmologic manifestations of Alzheimer’s disease. Surv Ophthalmol 34:31–43

    Article  CAS  PubMed  Google Scholar 

  17. Leuba G, Saini K (1995) Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer’s disease. Neuropathol Appl Neurobiol 21:410–422

    Article  CAS  PubMed  Google Scholar 

  18. Couser E, Bernstein SL (2014) Alzheimer-induced changes in biomarkers in the human lateral geniculate nucleus. Invest Ophthalmol Vis Sci 55(13):1850–1850

    Google Scholar 

  19. Stopa EG, Volicer L, Kuo-Leblanc V et al (1999) Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58:29–39

    Article  CAS  PubMed  Google Scholar 

  20. La Morgia C, Ross-Cisneros FN, Sadun AA, Hannibal J, Munarini A, Mantovani V, … & Salomao SR (2010) Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain awq155

  21. Iseki E, Matsushita M, Kosaka K et al (1989) Distribution and morphology of brain stem plaques in Alzheimer’s disease. Acta Neuropathol 78:131–136

    Article  CAS  PubMed  Google Scholar 

  22. Kuljis RO (1994) Lesions in the pulvinar in patients with Alzheimer’s disease. J Neuropathol Exp Neurol 53:202–211

    Article  CAS  PubMed  Google Scholar 

  23. Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 315:485–487. doi:10.1056/NEJM198608213150804

    Article  CAS  PubMed  Google Scholar 

  24. Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer’s disease I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17:377–384

    Article  CAS  PubMed  Google Scholar 

  25. Blanks JC, Schmidt SY, Torigoe Y et al (1996) Retinal pathology in Alzheimer’s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17:385–395

    Article  CAS  PubMed  Google Scholar 

  26. Sadun AA, Bassi CH (1990) Optic nerve damage in Alzheimer’s disease. Ophthalmology 97(1):9–17

    Article  CAS  PubMed  Google Scholar 

  27. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV et al (2011) Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage 54(Suppl 1):S204–S217

    Article  CAS  PubMed  Google Scholar 

  28. Dehabadi MH, Davis BM, Wong TK, Cordeiro MF (2014) Retinal manifestations of Alzheimer’s disease. Neurodegener Dis Manag 4(3):241–252

    Article  PubMed  Google Scholar 

  29. Guo L, Duggan J, Cordeiro MF (2010) Alzheimer’s disease and retinal neurodegeneration. Curr Alzheimer Res 7:3–14

    Article  CAS  PubMed  Google Scholar 

  30. Williams PA, Thirgood RA, Oliphant H et al (2013) Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer’s disease. Neurobiol Aging 34(7):1799–1806

    Article  CAS  PubMed  Google Scholar 

  31. Van Buren JM (1963) Trans-synaptic retrograde degeneration in the visual system of primates. J Neurol Neurosurg Psychiatry 26:402–409

    Article  PubMed Central  Google Scholar 

  32. Beatty RM, Sadun AA, Smith L, Vonsattel JP, Richardson EP Jr (1982) Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes. J Neurol Neurosurg Psychiatry 45:143–146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Fletcher WA, Hoyt WF, Narahara MH (1988) Congenital quadrantanopia with occipital lobe ganglioglioma. Neurology 38:1892–1894

    Article  CAS  PubMed  Google Scholar 

  34. Jindahra P, Petrie A, Plant GT (2009) Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 132:628–634

    Article  PubMed  Google Scholar 

  35. Jindahra P, Petrie A, Plant GT (2012) The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. Brain 135:534–541

    Article  PubMed  Google Scholar 

  36. Katsutoshi G et al (2016) Sectoral analysis of the retinal nerve fiber layer thinning and its association with visual field loss in homonymous hemianopia caused by post-geniculate lesions using spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 254:745–756

    Article  Google Scholar 

  37. Tsai CS, Ritch R, Schwartz B, Lee SS, Miller NR, CHI T et al (1991) Optic-nerve head and nerve-fiber layer in Alzheimer’s disease. Arch Ophthalmol 109:199–204

    Article  CAS  PubMed  Google Scholar 

  38. Hedges TR, Perez Galves R, Speigelman D, Barbas NR, Pelo E, Yardley CJ (1996) Retinal nerve fiber layer abnormalities in Alzheimer’s disease. Acta Ophthalmol Scand 74:271–275

    Article  PubMed  Google Scholar 

  39. Kromer R, Serbecic N, Hausner L, Froelich L & Beutelspacher SC (2013) Comparison of visual evoked potentials and retinal nerve fiber layer thickness in Alzheimer’s disease. Front Neurol 4

  40. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R et al (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: evidence in optic coherence tomography. Neurosci Lett 480:69–72

    Article  CAS  PubMed  Google Scholar 

  41. Ong Y-L, Ong Y-T, Cheung CY et al (2014) Potential applications of spectral-domain optical coherence tomography (SD-OCT) in the study of Alzheimer’s disease. Proceedings of Singapore Healthcare 23:1

  42. Danesh-Meyer HV, Birch H, Ku JY et al (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67:1852–1854

    Article  CAS  PubMed  Google Scholar 

  43. Parisi V, Restuccia R, Fattaposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol 112:1860–1867

    Article  CAS  PubMed  Google Scholar 

  44. Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18–24

    Article  PubMed  Google Scholar 

  45. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 48:2285–2289

    Article  PubMed  Google Scholar 

  46. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett 420:97–9

    Article  CAS  PubMed  Google Scholar 

  47. Kesler A, Vakhapova V, Korczyn AD, Naftaliev F, Neudorfer M (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin Neurol Neurosurg 113:523–526

    Article  PubMed  Google Scholar 

  48. Moschos MM, Markopoulos I, Chatziralli I, Vassilopoulos D et al (2012) Structural and functional impairment of the retina and optic nerve in Alzheimer’s disease. Curr Alzheimer Res 9:782–788

    Article  CAS  PubMed  Google Scholar 

  49. Marziani E, Pomati S, Ramolofo P et al (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer’s disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54:5953–5958

    Article  PubMed  Google Scholar 

  50. Ascaso FJ, Cruz N, Modrego PJ, Lopez-Anton R, Santabárbara J, Pascual LF et al (2014) Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study. J Neurol 261:1522–1530. doi:10.1007/s00415-014-7374-z

    Article  PubMed  Google Scholar 

  51. Garcia-Martin ES, Rojas B, Ramirez AI, de Hoz R, Salazar JJ, Yubero R, Gil P, Triviño A, Ramirez JM (2014) Macular thickness as a potential biomarker of mild Alzheimer’s disease. Ophthalmology 121(5):1149–1151-3

    Article  PubMed  Google Scholar 

  52. Salobrar-Garcia E, Hoyas I, Ramirez JM et al (2014) Analysis of retinal peripapillary segmentation in early Alzheimer’s disease patients. BioMed Res Int 1–8

  53. Gao LY, Liu Y, Li X, Bai Q, Liu P (2015) Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer’s disease. Arch Gerontol Geriatr 60:162–167

    Article  PubMed  Google Scholar 

  54. Cheung CYL, Ong YT, Hilal S et al (2015) Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 45(1):45–56

    CAS  PubMed  Google Scholar 

  55. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 12(12):723–738

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, Catindig JA, Venketasubramanian N, Yap P, Seow D, Chen CP, Wong TY (2014) Microvascular network alterations in the retina of patients with Alzheimer’s disease. Alzheimers Dement 10:135–142

    Article  PubMed  Google Scholar 

  57. Cheung CY, Ong YT, Ikram MK, Chen C, Wong TY (2014) Retinal microvasculature in Alzheimer’s disease. J Alzheimers Dis 42:S339–S352

    PubMed  Google Scholar 

  58. Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, AIBL Research Group (2013) Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease. Transl Psychiatry 3:e233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Ramrattan RS, van der Schaft TL, MOoy CM, de Brujin WC, Mulder PG, de Jong PT (1994) Morphometric analysis of Bruch’s membrane, the choriocapillaries, and the choroid in aging. Invest Ophthalmol Vis Sci 35(6):2857–2864

    CAS  PubMed  Google Scholar 

  60. Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58:387–429

    Article  PubMed  Google Scholar 

  61. Gharbiya M, Trebbastoni A, Parisi F, Campanelli A, Lena CD et al (2014) Choroidal thinning as a new finding in Alzheimer’s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis 40:907–917

    PubMed  Google Scholar 

  62. Bayhan HA, Aslan BS, Celikbilek A, Tanik N, Gurdal C (2015) Evaluation of the chorioretinal thickness changes in Alzheimer’s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol 43(2):145–151

    Article  PubMed  Google Scholar 

  63. Bulut M, Yaman A, Erol MK, Kurtuluş F, Toslak D, Doğan B, Kaya Başar E (2016) Choroidal thickness in patients with mild cognitive impairment and Alzheimer’s type dementia. J Ophthalmol. doi:10.1153/2016/7291257

    PubMed  PubMed Central  Google Scholar 

  64. Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC (2014) Detection of retinal nerve fiber layer defects in Alzheimer’s disease using SD-OCT. Front Psychol 5:22

    Google Scholar 

  65. Larrosa JM, Garcia-Martin E, Bambo MP, Pinilla J, Polo V, Otin S, Satue M, Herrero R, Pablo LE (2014) Potential new diagnostic tool for Alzheimer’s disease using a linear discriminant function for Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci 55(5):3043–3051

    Article  PubMed  Google Scholar 

  66. Polo V, Garcia-Martin E, Bambo MP, Pinilla J, Larrosa JM, Satue M, Otin S, Pablo LE (2014) Reliability and vailidity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer’s disease. Eye 28:680–690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Keller J, Sánchez-Dalmau BF, Villoslada P (2014) Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells. PLoS One 9(5):e97444. doi:10.1371/journal.pone.0097444

    Article  PubMed  PubMed Central  Google Scholar 

  68. Herro AM, Lam BL (2015) Retrograde degeneration of retinal ganglion cells in homonymous hemianopsia. Clin Ophthalmol 9:1057–1064

    Article  PubMed  PubMed Central  Google Scholar 

  69. Ong Y-T, Hilal S, Cheung CY, Venketasubramanian N, Niessen WJ, Vrooman H, Anuar AR, CHw M, Chen C, Wong TY, Ikram MK (2015) Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett 584:12–16. doi:10.1016/j.neulet.2014.10.010

    Article  CAS  PubMed  Google Scholar 

  70. Kirbas S, TUrkyilmaz K, Anlar O, Furekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33(1):58–61

    Article  PubMed  Google Scholar 

  71. Bambo MP, Garcia-Martin E, Otin S, Pinilla J, Larrosa JM, Polo V, Pablo LE (2015) Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia. Acta Ophthalmol 93(6):e507–e508

    Article  PubMed  Google Scholar 

  72. Liu D, Zhang L, Li Z, Zhang X, Wu Y, Yang H, Min B, Zhang X, Ma D, Lu Y (2015) Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer’s disease. BMC Neurol 15:14

    Article  PubMed  PubMed Central  Google Scholar 

  73. He X-F, Liu Y-T, Peng C, Zhang F, Zhuang S, Zhang J-S (2012) Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a meta-analysis. Int J Ophthalmol 5(3):401–405

    PubMed  PubMed Central  Google Scholar 

  74. Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S (2015) A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement 1:136–143

    Google Scholar 

  75. Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G et al (2015) Optical coherence tomography in Alzheimer’s disease: a meta-analysis. PLoS ONE 10(8):e0134750. doi:10.1371/journal.pone.0134750

    Article  PubMed  PubMed Central  Google Scholar 

  76. Moreno-Ramos T, Benito-Leon J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664

    CAS  PubMed  Google Scholar 

  77. Oktem EO, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U (2014) The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 36(7):1141–1146

    Article  Google Scholar 

  78. Choi W, Mohler KJ, Potsaid B, Lu CD, Liu JJ et al (2013) Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed OCT angiography. PLoS ONE 8(12):e81499. doi:10.1371/journal.pone.0081499

    Article  PubMed  PubMed Central  Google Scholar 

  79. McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269. doi:10.1016/j.jalz.2011.03.005

    Article  PubMed  PubMed Central  Google Scholar 

  80. Sperling RA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292. doi:10.1016/j.jalz.2011.03.003

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CHCL – Centro Hospitalar de Lisboa Central, Lisbon, Portugal

    J. P. Cunha, N. Moura-Coelho, R. P. Proença, A. Dias-Santos & J. Ferreira

  2. Nova Medical School/Faculdade de Ciências Médicas (NMS/FCM), Universidade Nova de Lisboa, Centro Hospitalar de Lisboa Central, Alameda Santo António dos Capuchos, 1169-050, Lisbon, Portugal

    J. P. Cunha, A. Dias-Santos, J. Ferreira & C. Louro

  3. VSRC-FML – Visual Sciences Research Centre, Faculty of Medicine of Lisbon, University of Lisbon, Lisbon, Portugal

    A. Castanheira-Dinis

Authors
  1. J. P. Cunha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Moura-Coelho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. P. Proença
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Dias-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Louro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Castanheira-Dinis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. P. Cunha.

Ethics declarations

Funding

No funding was received for this research.

Conflicts of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study, and for this type of study, formal consent is not required. This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

J. P. Cunha and N. Moura-Coelho are both first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cunha, J.P., Moura-Coelho, N., Proença, R.P. et al. Alzheimer’s disease: A review of its visual system neuropathology. Optical coherence tomography—a potential role as a study tool in vivo. Graefes Arch Clin Exp Ophthalmol 254, 2079–2092 (2016). https://doi.org/10.1007/s00417-016-3430-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3430-y

Keywords

Search

Navigation